China perseveres with mRNA COVID shot development amid Omicron, commercial uncertainty, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

China has spent over a year developing Pfizer-type COVID-19 vaccines that may even help it pivot from stringent “zero-COVID” restrictions, but a changed market and the Omicron variant have muddied prospects before efficacy data has even been published., China has spent over a year developing Pfizer-type COVID-19 vaccines that may even help it pivot from stringent “zero-COVID” restrictions, but a changed market and the Omicron variant have muddied prospects before efficacy data has even been published., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *